Penn Study Confirms That “Sniff Test” May Be Useful in Diagnosing Early Alzheimer’s Disease

December 22, 2016 - Tests that measure the sense of smell may soon become common in neurologists’ offices. Scientists have been finding increasing evidence that the sense of smell declines sharply in the early stages of Alzheimer’s, and now a new study from the Perelman School of Medicine at the University of Pennsylvania published in the Journal of Alzheimer’s Disease confirms that administering a simple “sniff test” can enhance the accuracy of diagnosing this dreaded disease. More...

December 22, 2016

New biomarker predicts Alzheimer’s disease and link to diabetes

December 22, 2016 - An enzyme found in the fluid around the brain and spine is giving researchers a snapshot of what happens inside the minds of Alzheimer’s patients and how that relates to cognitive decline. More...

December 22, 2016

Antipsychotic drug use increases risk of mortality among persons with Alzheimer’s disease

December 20, 2016 - Antipsychotic drug use is associated with a 60 percent increased risk of mortality among persons with Alzheimer's disease, shows a recent study from the University of Eastern Finland. The risk was highest at the beginning of drug use and remained increased in long-term use. Use of two or more antipsychotic drugs concomitantly was associated with almost two times higher risk of mortality than monotherapy. The results were published in the Journal of Alzheimer’s Disease. More...

December 20, 2016

JAD’s Alzheimer Funding Analyzer Now Includes Alzheimer’s Association Grants

December 19, 2016 - The Journal of Alzheimer’s Disease (JAD) is pleased to announce that its Alzheimer’s Funding Analyzer (AFA) now includes all Alzheimer’s Association (AA) grants in addition to grants from other funding bodies. AFA is a free service that is part of a suite of online features integrated into the JAD site to meet the needs of the Alzheimer disease (AD) research community. More...

December 19, 2016